Published in Cancer Weekly, February 2nd, 2010
"A total of 235 premenopausal women with pT1mic/pT1a breast cancer (n=21), or intraepithelial neoplasia (IEN, n=160), or 5-year Gail risk >or=1.3% (n=54) were randomly allocated to either tamoxifen 5...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.